Jennison Associates LLC Ovid Therapeutics Inc. Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$5.6 - $11.0 $2.21 Million - $4.34 Million	-394,436 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$6.16 - $10.14 $1.58 Million - $2.6 Million	-256,220 Reduced 39.38%	394,436 $3.08 Million
Q1 2018 Apr 20, 2018	BUY	$6.53 - $9.82 $474,411 - $713,432	72,651 Added 12.57%	650,656 $4.6 Million
Q4 2017 Jan 25, 2018	SELL	$6.12 - $12.31 $547,501 - $1.1 Million	-89,461 Reduced 13.4%	578,005 $5.71 Million
Q3 2017 Nov 03, 2017	BUY	$5.32 - $9.77 $3.55 Million - $6.52 Million	667,466	667,466 $5.86 Million

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.